bufalin has been researched along with Invasiveness, Neoplasm in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (81.82) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Dou, H; Su, S; Wang, Z; Zhang, Q | 1 |
Li, H; Qin, J; Sheng, X; Zhang, J; Zhao, H; Zhao, Y; Zhu, P | 1 |
Qiu, DZ; Wu, WZ; Yang, YK; Zhang, ZJ | 1 |
Chang, JB; Chang, SJ; Chen, YY; Chung, JG; Hsu, SC; Kuo, CL; Lee, CH; Lin, JJ; Liu, JY; Lu, HF; Wu, PP | 1 |
Feng, W; Hu, Q; Hu, SJ; Liang, B; Peng, W; Qiu, YY; Tang, QF; Yin, PH | 1 |
Chen, JC; Chung, JG; Hsia, TC; Hsiao, YT; Hsu, SC; Hsu, WH; Kuo, CL; Liu, HC; Wu, PP; Wu, SH; Yu, FS | 1 |
Gai, JQ; Ni, L; Qin, JM; Sheng, X; Sun, K; Zhao, W | 1 |
Chi, H; Jiang, F; Meng, Z; Ning, Z; Wang, H; Xu, L; Zang, K; Zhang, C; Zhu, X | 1 |
Cheng, YD; Chung, JG; Hsia, TC; Hsiao, YT; Huang, AC; Kuo, CL; Lin, TS; Ma, YS; Peng, SF; Yang, MD | 1 |
Chen, YY; Chueh, FS; Chung, JG; Ho, HC; Huang, AC; Kuo, CL; Liao, CL; Yang, JS | 1 |
Chang, YC; Choi, YH; Hong, SH; Kim, GY; Kim, WJ; Moon, SK | 1 |
11 other study(ies) available for bufalin and Invasiveness, Neoplasm
Article | Year |
---|---|
Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-α pathway.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bufanolides; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice, Nude; Neoplasm Invasiveness; Ovarian Neoplasms; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin.
Topics: Antineoplastic Agents; Bufanolides; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Patents as Topic; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; beta Catenin; Bufanolides; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Signal Transduction | 2013 |
Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathways.
Topics: Antineoplastic Agents; Bufanolides; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NF-kappa B; Signal Transduction | 2015 |
MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Bufanolides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Humans; Male; Mice; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction | 2014 |
Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways.
Topics: Bufanolides; Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Signal Transduction | 2015 |
The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway.
Topics: Bufanolides; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Phosphorylation; Wnt Signaling Pathway | 2016 |
Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bufanolides; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro.
Topics: Antineoplastic Agents; Bufanolides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Quinazolines; rhoA GTP-Binding Protein; Signal Transduction; SOS1 Protein | 2016 |
Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.
Topics: Antineoplastic Agents; Bone Neoplasms; Bufanolides; Cell Line, Tumor; Cell Movement; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Osteosarcoma; Protein Kinase Inhibitors | 2014 |
Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bufanolides; Cell Movement; Cell Proliferation; Electric Impedance; Humans; Matrix Metalloproteinases; Neoplasm Invasiveness; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Tight Junctions; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Wound Healing | 2013 |